Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and treatment of Hidradenitis Suppurativa are important to prevent serious physical and mental effects.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Testosterone's muscle-building effects do not require its conversion to DHT.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

Testicular microlithiasis may increase the risk of testicular cancer and patients with it should be closely monitored.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

Thermal spring waters and their microbes could be good for skin health and treating some skin conditions in skincare products.

Female pattern hair loss is common and should be treated early to prevent worsening, with Minoxidil being the main approved treatment.

More research is needed to find effective treatments for Female Pattern Hair Loss.

Puberty involves complex hormonal changes, varies by gender and ethnicity, and requires careful monitoring for abnormalities.

Higher early lead exposure is linked to delayed puberty in girls.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Higher fluoride levels may delay puberty in boys.

PFAS exposure in adolescence may delay puberty in females.

Low selenium intake may delay puberty in boys but not in girls.

Hormones during puberty increase certain receptors in the brain, and this change is influenced by estrogen levels.

Accurate assessment of puberty using Tanner staging is crucial for identifying normal and abnormal development.

Girls with PCOS often start puberty earlier and have signs of insulin resistance from a young age.

Recurrent vaginal bleeding in young girls without puberty signs may require a genital exam to find hidden causes.

Rural Bangladeshi girls mature later than peers in other low and middle-income countries due to poor nutrition and socioeconomic conditions.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

The girl's unexpected pubic hair growth led to a diagnosis different from complete androgen insensitivity syndrome.

Androgenetic alopecia is a long-term, immune-related disorder that starts during puberty due to androgen secretion, and it might be improved with iron tablets, platelet transfusion, and anti-inflammation therapy.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Babies who gain weight quickly, especially in the first 3 months, may start puberty earlier.